Is uniQure N.V. (QURE) a Buy, Sell, or Hold?
uniQure N.V.
NASDAQ:QURE
$41 USD
-$0.52 (-1.25%)
- Volume
- 903.09K
- Average Volume
- 2.2M
- Market Capitalization
- $2.79B
- P/E Ratio
- -11.68
- Dividend Yield
- 0.00%
- Price Target
- $63.00
- Year High
- $71.50
- Year Low
- $8.73
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $10.40
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
48
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
85
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$ 1.38M
QURE Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
QURE Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Kapusta Matthew C | director, officer: CEO, Managing Director | 2026-07-02 | M-Exempt | 19.39 | 2026-07-07 |
| Kapusta Matthew C | director, officer: CEO, Managing Director | 2026-07-02 | S-Sale | 44.43 | 2026-07-07 |
| Kapusta Matthew C | director, officer: CEO, Managing Director | 2026-07-02 | S-Sale | 45.43 | 2026-07-07 |
| Kapusta Matthew C | director, officer: CEO, Managing Director | 2026-07-02 | S-Sale | 45.89 | 2026-07-07 |
| Kapusta Matthew C | director, officer: CEO, Managing Director | 2026-07-02 | M-Exempt | 19.39 | 2026-07-07 |
| Abi-Saab Walid | officer: Chief Medical Officer | 2026-06-30 | M-Exempt | 5.59 | 2026-07-02 |
| Abi-Saab Walid | officer: Chief Medical Officer | 2026-06-30 | S-Sale | 46.46 | 2026-07-02 |
| Abi-Saab Walid | officer: Chief Medical Officer | 2026-06-30 | S-Sale | 46.4 | 2026-07-02 |
| Abi-Saab Walid | officer: Chief Medical Officer | 2026-06-30 | M-Exempt | 5.59 | 2026-07-02 |
| Kaye Jack | director | 2026-06-30 | M-Exempt | 20.18 | 2026-07-02 |
| Kaye Jack | director | 2026-06-30 | M-Exempt | 37 | 2026-07-02 |
| Kaye Jack | director | 2026-06-30 | S-Sale | 46.43 | 2026-07-02 |
| Kaye Jack | director | 2026-06-30 | S-Sale | 46.49 | 2026-07-02 |
| Kaye Jack | director | 2026-06-30 | M-Exempt | 20.18 | 2026-07-02 |
| Kaye Jack | director | 2026-06-30 | M-Exempt | 37 | 2026-07-02 |
| Abi-Saab Walid | officer: Chief Medical Officer | 2026-06-26 | S-Sale | 46.86 | 2026-06-30 |
| Kapusta Matthew C | director, officer: CEO, Managing Director | 2026-06-25 | M-Exempt | 31.71 | 2026-06-26 |
| Kapusta Matthew C | director, officer: CEO, Managing Director | 2026-06-24 | M-Exempt | 31.71 | 2026-06-26 |
| Kapusta Matthew C | director, officer: CEO, Managing Director | 2026-06-24 | S-Sale | 50 | 2026-06-26 |
| Kapusta Matthew C | director, officer: CEO, Managing Director | 2026-06-25 | S-Sale | 50.02 | 2026-06-26 |
| Kapusta Matthew C | director, officer: CEO, Managing Director | 2026-06-24 | M-Exempt | 31.71 | 2026-06-26 |
| Kapusta Matthew C | director, officer: CEO, Managing Director | 2026-06-25 | M-Exempt | 31.71 | 2026-06-26 |
| Kapusta Matthew C | director, officer: CEO, Managing Director | 2026-06-17 | M-Exempt | 19.39 | 2026-06-22 |
| Kapusta Matthew C | director, officer: CEO, Managing Director | 2026-06-17 | S-Sale | 42.61 | 2026-06-22 |
| Kapusta Matthew C | director, officer: CEO, Managing Director | 2026-06-17 | S-Sale | 43.7 | 2026-06-22 |
| Kapusta Matthew C | director, officer: CEO, Managing Director | 2026-06-17 | S-Sale | 45.02 | 2026-06-22 |
| Kapusta Matthew C | director, officer: CEO, Managing Director | 2026-06-17 | S-Sale | 43.43 | 2026-06-22 |
| Kapusta Matthew C | director, officer: CEO, Managing Director | 2026-06-17 | S-Sale | 45.01 | 2026-06-22 |
| Kapusta Matthew C | director, officer: CEO, Managing Director | 2026-06-18 | M-Exempt | 31.71 | 2026-06-22 |
| Kapusta Matthew C | director, officer: CEO, Managing Director | 2026-06-17 | S-Sale | 48.65 | 2026-06-22 |
| Kapusta Matthew C | director, officer: CEO, Managing Director | 2026-06-18 | S-Sale | 50 | 2026-06-22 |
| Kapusta Matthew C | director, officer: CEO, Managing Director | 2026-06-18 | S-Sale | 50 | 2026-06-22 |
| Kapusta Matthew C | director, officer: CEO, Managing Director | 2026-06-18 | M-Exempt | 31.71 | 2026-06-22 |
| Kapusta Matthew C | director, officer: CEO, Managing Director | 2026-06-17 | M-Exempt | 19.39 | 2026-06-22 |
| Balachandran Madhavan | director | 2026-06-17 | M-Exempt | 19.39 | 2026-06-22 |
| Balachandran Madhavan | director | 2026-06-17 | S-Sale | 47.08 | 2026-06-22 |
| Balachandran Madhavan | director | 2026-06-17 | M-Exempt | 31.71 | 2026-06-22 |
| Balachandran Madhavan | director | 2026-06-17 | S-Sale | 43.66 | 2026-06-22 |
| Balachandran Madhavan | director | 2026-06-17 | S-Sale | 42.6 | 2026-06-22 |
| Balachandran Madhavan | director | 2026-06-17 | M-Exempt | 31.71 | 2026-06-22 |
| Balachandran Madhavan | director | 2026-06-17 | M-Exempt | 19.39 | 2026-06-22 |
| Kaye Jack | director | 2026-06-17 | M-Exempt | 31.71 | 2026-06-22 |
| Kaye Jack | director | 2026-06-17 | S-Sale | 42.57 | 2026-06-22 |
| Kaye Jack | director | 2026-06-17 | M-Exempt | 31.71 | 2026-06-22 |
| Balachandran Madhavan | director | 2026-06-15 | M-Exempt | 8.49 | 2026-06-17 |
| Balachandran Madhavan | director | 2026-06-15 | S-Sale | 27.85 | 2026-06-17 |
| Balachandran Madhavan | director | 2026-06-15 | M-Exempt | 8.49 | 2026-06-17 |
| Potts Jeannette | officer: Chief Legal Officer | 2026-06-15 | S-Sale | 27.67 | 2026-06-17 |
| Meek David D. | director | 2026-06-10 | A-Award | 0 | 2026-06-12 |
| Meek David D. | director | 2026-06-11 | S-Sale | 27.06 | 2026-06-12 |
| Meek David D. | director | 2026-06-10 | A-Award | 26.82 | 2026-06-12 |
| Gut Robert | director | 2026-06-10 | M-Exempt | 16.04 | 2026-06-12 |
| Gut Robert | director | 2026-06-10 | A-Award | 0 | 2026-06-12 |
| Gut Robert | director | 2026-06-10 | S-Sale | 26.07 | 2026-06-12 |
| Gut Robert | director | 2026-06-11 | S-Sale | 27.06 | 2026-06-12 |
| Gut Robert | director | 2026-06-10 | S-Sale | 26.03 | 2026-06-12 |
| Gut Robert | director | 2026-06-10 | S-Sale | 26.05 | 2026-06-12 |
| Gut Robert | director | 2026-06-10 | A-Award | 26.82 | 2026-06-12 |
| Gut Robert | director | 2026-06-10 | M-Exempt | 16.04 | 2026-06-12 |
| O'Keefe Kylie | officer: Chief Customer & Strat Officer | 2026-06-11 | S-Sale | 27.06 | 2026-06-12 |
| Springhorn Jeremy P. | director | 2026-06-10 | A-Award | 0 | 2026-06-12 |
| Springhorn Jeremy P. | director | 2026-06-11 | S-Sale | 27.06 | 2026-06-12 |
| Springhorn Jeremy P. | director | 2026-06-10 | A-Award | 26.82 | 2026-06-12 |
| POST LEONARD E | director | 2026-06-10 | A-Award | 0 | 2026-06-12 |
| POST LEONARD E | director | 2026-06-11 | S-Sale | 27.06 | 2026-06-12 |
| POST LEONARD E | director | 2026-06-10 | A-Award | 26.82 | 2026-06-12 |
| Kaye Jack | director | 2026-06-10 | A-Award | 0 | 2026-06-12 |
| Kaye Jack | director | 2026-06-11 | S-Sale | 27.06 | 2026-06-12 |
| Kaye Jack | director | 2026-06-10 | A-Award | 26.82 | 2026-06-12 |
| Jacques Rachelle Suzanne | director | 2026-06-10 | A-Award | 0 | 2026-06-12 |
| Jacques Rachelle Suzanne | director | 2026-06-11 | S-Sale | 27.06 | 2026-06-12 |
| Jacques Rachelle Suzanne | director | 2026-06-10 | A-Award | 26.82 | 2026-06-12 |
| Balachandran Madhavan | director | 2026-06-10 | A-Award | 0 | 2026-06-12 |
| Balachandran Madhavan | director | 2026-06-11 | S-Sale | 27.06 | 2026-06-12 |
| Balachandran Madhavan | director | 2026-06-10 | A-Award | 26.82 | 2026-06-12 |
| Kaye Jack | director | 2026-06-03 | M-Exempt | 16.04 | 2026-06-05 |
| Kaye Jack | director | 2026-06-03 | S-Sale | 30.01 | 2026-06-05 |
| Kaye Jack | director | 2026-06-03 | M-Exempt | 16.04 | 2026-06-05 |
| Abi-Saab Walid | officer: Chief Medical Officer | 2026-05-08 | M-Exempt | 5.59 | 2026-05-12 |
| Abi-Saab Walid | officer: Chief Medical Officer | 2026-05-08 | S-Sale | 25.1 | 2026-05-12 |
| Abi-Saab Walid | officer: Chief Medical Officer | 2026-05-08 | S-Sale | 25 | 2026-05-12 |
| Abi-Saab Walid | officer: Chief Medical Officer | 2026-05-08 | M-Exempt | 5.59 | 2026-05-12 |
| O'Keefe Kylie | officer: Chief Customer & Strat Officer | 2026-03-04 | A-Award | 0 | 2026-03-09 |
| O'Keefe Kylie | officer: Chief Customer & Strat Officer | 2026-03-04 | A-Award | 9.04 | 2026-03-09 |
| O'Keefe Kylie | officer: Chief Customer & Strat Officer | 2026-02-25 | 0 | 2026-03-09 | |
| O'Keefe Kylie | officer: Chief Customer & Strat Officer | 2026-02-25 | 16.22 | 2026-03-09 | |
| Kapusta Matthew C | director, officer: CEO, Managing Director | 2026-03-04 | A-Award | 0 | 2026-03-06 |
| Kapusta Matthew C | director, officer: CEO, Managing Director | 2026-03-04 | S-Sale | 9.06 | 2026-03-06 |
| Kapusta Matthew C | director, officer: CEO, Managing Director | 2026-03-04 | A-Award | 9.04 | 2026-03-06 |
| Abi-Saab Walid | officer: Chief Medical Officer | 2026-03-04 | A-Award | 0 | 2026-03-06 |
| Abi-Saab Walid | officer: Chief Medical Officer | 2026-03-04 | S-Sale | 9.06 | 2026-03-06 |
| Abi-Saab Walid | officer: Chief Medical Officer | 2026-03-04 | A-Award | 9.04 | 2026-03-06 |
| Potts Jeannette | officer: Chief Legal Officer | 2026-03-04 | A-Award | 0 | 2026-03-06 |
| Potts Jeannette | officer: Chief Legal Officer | 2026-03-04 | S-Sale | 9.06 | 2026-03-06 |
| Potts Jeannette | officer: Chief Legal Officer | 2026-03-04 | A-Award | 9.04 | 2026-03-06 |
| KLEMT CHRISTIAN | officer: Chief Financial Officer | 2026-03-04 | A-Award | 0 | 2026-03-06 |
| KLEMT CHRISTIAN | officer: Chief Financial Officer | 2026-03-04 | S-Sale | 9.06 | 2026-03-06 |
| KLEMT CHRISTIAN | officer: Chief Financial Officer | 2026-03-04 | A-Award | 9.04 | 2026-03-06 |
| Kapusta Matthew C | director, officer: CEO, Managing Director | 2026-03-02 | S-Sale | 9.95 | 2026-03-04 |
| KLEMT CHRISTIAN | officer: Chief Financial Officer | 2026-03-02 | S-Sale | 9.95 | 2026-03-04 |